Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by PeterMacd2on Jun 16, 2019 5:25pm
199 Views
Post# 29830567

RE:RE:RE:RE:RE:RE:RE:Thoughts on Rec. 2.0 Regulations and where we are at

RE:RE:RE:RE:RE:RE:RE:Thoughts on Rec. 2.0 Regulations and where we are atI agree that's a good start. I hope it's enough to confer an advantage. How many of those strains have been fully evaluated for potential bud and CBD or THC production? My point was that if the genetics boffins' claims are correct about their new "manipulated" strains - 2 to 5 fold higher CBDs yield and higher percentage of water-soluble CBDs than any "natural" genotype - then any grower not connected into that is going to be at a big disadvantage in the long term.  Look at the Trait news url I gave before.  I am very, very long (suffering) on APH, so don't get my intentions wrong. My retirement depends on them. I'm just pointing out that the science into cannabis seems to be rapidly throwing up new discoveries that perhaps more traditional growers would never have thought possible. APH's success long-term as a grower depends on being at the forefront of the science; I don't see any evidence (commentary by IS, news releases, high-level science staff appointments) that they even know about the new science.
Bullboard Posts